Ligand Pro, founded by Skoltech researchers in Moscow, unveiled Matcha, an AI model that screens drug candidates 30 times faster than AlphaFold-class models while achieving superior accuracy. This breakthrough accelerates virtual drug development and
← News
Tech for Good Tech for Good Frontiers
Matcha model makes drug candidate screening more than 30 times faster
30x Faster Speed advantage
AlphaFold-Class Models Compared to
Superior Accuracy improvement
Ligand Pro (Skoltech) Organization
Surpassed AlphaFold accuracy
Breakthrough AI Model milestone
Drug Screening application